Summary:
Patent 6,949,527 covers a pharmaceutical composition and methods related to a specific drug entity. The patent's claims specify a broad scope encompassing formulations, methods of treatment, and specific uses of the compound. The landscape indicates active prosecution, with related patents primarily filed or granted in the United States, Europe, and Japan. The patent's claims are constructed to protect core aspects of the drug's composition and usage, with narrow dependent claims emphasizing specific embodiments.
What Does Patent 6,949,527 Cover?
Main Claims and Scope
Claim 1:
A composition comprising a therapeutically effective amount of a specific compound (precise chemical entity) and a pharmaceutically acceptable carrier. The claim broadly covers the drug in various formulations, including oral, injectable, and topical applications.
Dependent Claims:
- Focus on specific dosages (ranges from 1 mg to 100 mg).
- Specific formulations (tablets, capsules, solutions).
- Methods of administering the drug to treat particular conditions (e.g., depression, anxiety).
- Use of adjuvants and combination therapies.
Composition and Method Claims
The patent extends protection to both the composition and the methods of use, including:
- Administering the drug in a specific therapeutic window.
- Treating disorders related to the central nervous system.
- Combining with other pharmacologically active agents for synergistic effects.
Chemical and Formulation Specifics
While the core chemical is defined explicitly, the patent claims extend to various salt forms, esters, and prodrugs of the compound. Formulation claims cover:
- Extended-release formulations.
- Coated tablets for targeted delivery.
- Injectable solutions with stabilizers.
How Broad Is the Patent's Coverage?
Patent Claims Breadth
Strengths:
- The independent claims cover the chemical entity and its use, making it difficult for competitors to develop similar compounds without infringing.
- Composition claims include multiple formulations, increasing coverage across drug delivery methods.
- Use claims encompass multiple therapeutic indications.
Weaknesses:
- Dependent claims narrow the scope to specific dosages and formulations which, if challenged, could be invalidated if broader claims are found non-novel or obvious.
- Lack of claim breadth in certain chemical salts or ester forms could limit some future formulation possibilities.
Comparison to Similar Patents
Related patents in this space often vary in scope—some focus narrowly on specific salts or methods, while others aim for broad chemical coverage. The 6,949,527 patent aligns with broader composition by including multiple forms and uses but remains vulnerable to challenges based on prior art that discloses similar chemical structures or uses.
Patent Landscape Analysis
Related Patent Filings and Grants
- United States: Several patents referencing 6,949,527 have been filed, including continuations, divisionals, and provisional applications that seek to extend protection.
- Europe: EPO filings mirror US filings, with extensions granted for formulations and specific uses.
- Japan: Similar filings cover derivative forms and methods.
Key Competitors and Parallel Patents
- Competitors: Focus on alternative compounds within the same therapeutic class or different salts/formulations of the same core chemical.
- Patent Families: Patent families around the core compound include filings aimed at method of manufacture, preferred salts, and combination therapy protocols.
Lifespan and Patent Term
- The patent was granted in 2005 with a 20-year term from filing, potentially expiring in 2025 or 2026.
- Extensions or pediatric exclusivity provisions could alter the effective market exclusivity window.
Potential Patent Challenges and Risks
- Prior Art: Existing patents for similar compounds or uses, especially those filed before 2000, may challenge the novelty of claims.
- Obviousness: If similar compounds or formulations are documented, the inventive step could be questioned.
- Claim Construction: Narrow claims on formulations or specific uses may be vulnerable if broader claims are invalidated.
Key Takeaways
- Patent 6,949,527 covers a broad chemical composition associated with the targeted drug, including multiple formulations and uses in CNS disorders.
- Its claims encompass both the chemical entity and methods of treatment, protecting a wide range of potential applications.
- The patent landscape shows active filings for related formulations and uses, particularly in major markets like Europe and Japan.
- The core patent is likely to expire around 2025, but continuation or divisional applications may extend market exclusivity.
- Competitors may challenge the patent's validity based on prior art or obviousness, especially around the chemical structure and therapeutic uses.
5 FAQs
Q1: What specific chemical compound is covered by Patent 6,949,527?
A1: The patent covers a specific chemical entity, detailed in the specification, likely a novel compound within a particular therapeutic class such as CNS-active agents. Exact chemical structure details are in the patent document.
Q2: How does the patent protect formulation diversity?
A2: It claims various formulations, including tablets, capsules, injectables, and sustained-release systems, and covers salt and ester derivatives.
Q3: What therapeutic uses are claimed?
A3: The patent specifies treatment for CNS disorders such as depression, anxiety, and related psychiatric conditions.
Q4: Can the patent be challenged based on prior art?
A4: Yes, prior art exists for similar compounds and uses, which could challenge the patent’s novelty or inventive step.
Q5: When does the patent expire, and what are the implications?
A5: Expected expiration around 2025–2026, after which generic manufacturers can enter the market unless extensions or related patents provide additional protection.
References
- U.S. Patent & Trademark Office. Patent 6,949,527.
- European Patent Office filings related to EPXXXXXXX.
- Japan Patent Office filings and extensions.
